[1] |
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood,2016, 127(20):2375-2390.
doi: 10.1182/blood-2016-01-643569
URL
|
[2] |
Hong M, Ko YH, Yoo KH, et al. EBV-positive T/NK-cell lymphoproliferative disease of childhood[J]. Korean J Pathol, 2013, 47(2):137-147.
doi: 10.4132/KoreanJPathol.2013.47.2.137
URL
|
[3] |
周小鸽, 张燕林, 谢建兰, 等. 对 EB 病毒相关淋巴组织增殖性疾病的理解和认识对[J]. 中华病理学杂志, 2016, 45(12):817-821.
|
[4] |
Virelizier JL, Lenoir G, Griscelli C. Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion[J]. Lancet, 1978, 2(8083):231-234.
pmid: 79029
|
[5] |
Quintanilla-Martinez L, Kimura H, Jaffe ES, et al. EBV-positive T-cell lymphoproliferative disorders of childhood fM1[M]// Swerdlow S, Campo E, Harris NL, et al. World Health Organization classification of tumors. WHO classification of tumours of haematopoi eric and lymphoid tissues. France: IARC Press, 2008:278-280.
|
[6] |
Sevilla DW, El-Mallawany NK, Emmons FN, et al. Spectrum of childhood Epstein-Barr virus-associated T-cell proliferations and bone marrow findings[J]. Pediatr Dev Pathol, 2011, 14(1):28-37.
doi: 10.2350/09-12-0753-OA.1
URL
|
[7] |
Rodríguez-Pinilla SM, Barrionuevo C, García J, et al. Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases[J]. Histopathology, 2011, 59(6):1183-1193.
doi: 10.1111/j.1365-2559.2011.04047.x
pmid: 22175898
|
[8] |
Xiao HJ, Li J, Song HM, et al. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders manifested as gastrointestinal perforations and skin lesions: A case report[J]. Medicine (Baltimore), 2016, 95(5):e2676.
doi: 10.1097/MD.0000000000002676
URL
|
[9] |
Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection[J]. Blood. 2001 Jul 15; 98(2):280-286.
doi: 10.1182/blood.v98.2.280
pmid: 11435294
|
[10] |
Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection[J]. J Infect Dis, 2003, 187(4):527-533.
doi: 10.1086/367988
URL
|
[11] |
金妍, 周小鸽, 何乐健, 等. 儿童系统性EB病毒阳性T细胞淋巴组织增殖性疾病的临床病理观察[J]. 中华病理学杂志, 2009, 38(9):600-608.
|
[12] |
Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection[J]. Am J Hematol, 2005, 80(1):64-69.
doi: 10.1002/ajh.20398
URL
|
[13] |
王杰松, 杨瑜, 何鸿鸣, 等. P-Gemox方案与P-GDP方案治疗NK/T细胞淋巴瘤的疗效比较[J]. 安徽医学, 2018, 39(10):1202-1206
|
[14] |
Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases[J]. Blood, 2012, 119(3):673-686.
doi: 10.1182/blood-2011-10-381921
URL
|
[15] |
王微, 遆红娟, 农琳, 等. 儿童系统性EB病毒阳性T细胞淋巴增殖性疾病临床病理学分析[J]. 北京大学学报:医学版, 2012, 44(4):594-598.
|
[16] |
Leeborg N, Russell T, Fan G. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood[J]. Pathol Case Rev, 2012, 17:120-124.
doi: 10.1097/PCR.0b013e318258eeba
URL
|
[17] |
Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection[J]. Blood, 2001, 98(2):280-286.
doi: 10.1182/blood.v98.2.280
pmid: 11435294
|
[18] |
Sato E, Ohga S, Kuroda H, et al. Allogeneic hematopoie-tic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan[J]. Am J Hematol, 2008, 83(9):721-727.
doi: 10.1002/ajh.21247
URL
|
[19] |
Kawa K, Sawada A, Sato M, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection[J]. Bone Marrow Transplant, 2011, 46(1):77-83.
doi: 10.1038/bmt.2010.122
URL
|